Biomerics LLC, a medical device contract manufacturer headquartered in Salt Lake City, has acquired FutureMatrix Interventional Inc. (FMI) of Athens, Texas. FMI specializes in the design and manufacture of interventional catheters for the cardiovascular and urinary markets.
“We are pleased to add FMI’s capabilities to the Biomerics portfolio,” said Biomerics CEO Travis Sessions. “We welcome the FMI team to the group and look forward to their contribution. This acquisition expands our capabilities and important customer relationships. We look forward to investing in and expanding the business for our customers, employees and community. Combining FMI with Biomerics’ existing medical device business establishes Biomerics as a leader in the attractive minimally invasive interventional segment of the medical device market.”